期刊簡介 | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Molecular Cancer LetPub Score 8.5
52 ratings
Rate
Reputation 8.6 Influence 8.3 Speed 8.7 | ||||||||||||||||||||||||
期刊簡稱 | MOL CANCER | ||||||||||||||||||||||||
ISSN | 1476-4598 | ||||||||||||||||||||||||
h-index | 103 | ||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||
自引率 (2023-2024) | 2.20%自引率趨勢 | ||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||
官方網站 | http://molecular-cancer.biomedcentral.com | ||||||||||||||||||||||||
在線稿件提交 | https://submission.nature.com/new-submission/12943/3 | ||||||||||||||||||||||||
開放訪問 | Yes | ||||||||||||||||||||||||
出版商 | BioMed Central | ||||||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||||||
出版國/地區 | ENGLAND | ||||||||||||||||||||||||
發行頻率 | 月刊 | ||||||||||||||||||||||||
創刊年 | 2002 | ||||||||||||||||||||||||
每年文章數 | 165每年文章數趨勢 | ||||||||||||||||||||||||
黃金OA百分比 | 100.00% | ||||||||||||||||||||||||
OA Related Info | APC: Yes( EUR3990; USD4890; GBP3490; ) APC waiver:Check Notes Other charges: No Keywords: oncology、tumour biology、cancer antigens Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | ||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1476-4598%5BISSN%5D | ||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Average 2 Month(s) | ||||||||||||||||||||||||
競爭力 * | 來自作者的數據: About 50% | ||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 3 4 5 6 7 下一頁 末頁 (頁 | |
[Molecular Cancer] 的評論 | 撰寫評論 |
作者: 邵鎏日 領域: 医学 審稿時間: 4.0 month(s) 結果: 修改後接受 撰寫評論 |
2024-06-03 17:09:15 評論於 Personal experience, this magazine is really not a light read, with very high demands for experimental data. A small paper was submitted to the same laboratory before, but it was rejected instantly... This submission took 4 months, with plenty of experimental data included in the initial submission. The reviewers gave very professional advice, requested additional experiments, and after adding 2 Figures of experiments, the revised paper went through rigorous review and was accepted. The editor then requested all original data for WB, giving only 2 days to submit... Looking back, most research articles of the past year have been of high quality, showing that the magazine now has very high expectations for the quality of submissions, and is determined to aim for top publications. Looking forward to even better results!(0) 讚! | 邵鎏日 |
作者: 赫然郎 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-17 23:42:47 評論於 Do you need to provide the raw data? Do you need the full uncut film for Weibo?(0) 讚! | 赫然郎 |
作者: 赫然郎 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-17 20:12:21 評論於 Do you need the raw data? Do you need to provide the uncut full film?(0) 讚! | 赫然郎 |
作者: 赫然郎 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-17 17:39:33 評論於 Do we need to provide the full film of Weicutting for WB?(0) 讚! | 赫然郎 |
作者: 小鹤 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-16 01:23:06 評論於 Sharing + recording the experience of submitting manuscripts A review article on a single tumor was rejected by STTT after one week, and then resubmitted to MC after revision. The initial check was completed within 2 days, and the revised manuscript was returned on the same day after formatting requirements were met. It was sent for peer review the next day. Three reviewers accepted the invitation on the 2nd, 3rd, and 4th day after inviting reviewers. Waiting(0) 讚! | 小鹤 |
作者: Lucy Larkin 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-12 19:16:15 評論於 Some non-coding RNAs are indeed relatively light. The submission difficulty of other types of articles is gradually increasing(0) 讚! | Lucy Larkin |
作者: 中原凝风 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-08 20:36:25 評論於 What is the status now? Will it be directly returned for rework or is there another status?(0) 讚! | 中原凝风 |
作者: 中原凝风 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-08 18:30:27 評論於 How long does it usually take for the first instance to reply?(0) 讚! | 中原凝风 |
作者: 凌霄子芸 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-25 18:04:02 評論於 I have been using this submission system for over a month, and there's nothing in it(0) 讚! | 凌霄子芸 |
作者: 北冥俊远 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-20 14:56:16 評論於 Research focus: Tumor experience sharing: Hey experts! Has there been any change in the submission status of this journal? It has always been in peer review status. How do we know if it is under review?(0) 讚! | 北冥俊远 |
作者: 北冥俊远 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-19 17:07:26 評論於 Am I in the same status for review too?(0) 讚! | 北冥俊远 |
作者: 北冥俊远 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-19 11:42:46 評論於 Acceptance(0) 讚! | 北冥俊远 |
作者: 北冥俊远 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-18 19:01:48 評論於 Have you cast your vote, my friend?(0) 讚! | 北冥俊远 |
作者: 北冥俊远 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-18 16:02:07 評論於 Did you submit it for review? Will you receive an email notification???(0) 讚! | 北冥俊远 |
作者: 北冥俊远 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-18 11:50:14 評論於 Do you send emails for approval meetings?(0) 讚! | 北冥俊远 |
作者: 西风稷骞 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-16 08:16:12 評論於 How are you doing now?(0) 讚! | 西风稷骞 |
作者: 冬晴姑娘 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-13 22:22:50 評論於 Hello, may I ask if Nature Cancer accepts unsolicited reviews?(0) 讚! | 冬晴姑娘 |
作者: 稻妻素琴 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-09 10:55:01 評論於 May I ask what is the current status of your manuscript?(0) 讚! | 稻妻素琴 |
作者: 凌霄子芸 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-17 11:53:58 評論於 After my technical check, it is peer review, but the main interface only shows that my technical check has passed. Does this mean it has been submitted for review?(0) 讚! | 凌霄子芸 |
作者: 仲夏和平 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-15 10:20:59 評論於 Review speed: 3.0 Research focus: cancer Experience sharing: Submitted before Christmas, still in peer review after three months, indicating that The editors' decision can take several weeks as they may consult peer reviewers(0) 讚! | 仲夏和平 |
作者: 南烟小可爱 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-12 12:29:00 評論於 There shouldn't be too much personal relationships mentioned in the article, it's all talk and no substance(0) 讚! | 南烟小可爱 |
作者: Lucy Larkin 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-06 22:51:08 評論於 Review speed: 2.0 | Submission hit rate: 5.0 Research focus: Tumors; Sharing experience in tumor chemotherapy: It is already quite difficult to submit a molecular cancer research series article with a hard submission now. Of course, there are some low-level articles related to non-coding RNA in the journal. Although journals like Big CDD, Nature, Journal of Hepatology, Cancer Research, Advanced Science, etc., sometimes publish related articles, the quality of the articles is not much different. In this regard, I hope that the Molecular Cancer journal can make improvements(0) 讚! | Lucy Larkin |
作者: 仲夏和平 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-02-25 20:39:12 評論於 I have also been peer reviewing for two months, and I have received one reviewer report(0) 讚! | 仲夏和平 |
作者: 晔晔公子 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-02-02 08:40:58 評論於 How do I know if I have invited reviewers? Did you send an email notification?(0) 讚! | 晔晔公子 |
作者: 晔晔公子 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-02-01 23:01:45 評論於 How long have you been waiting? When did you apply?(0) 讚! | 晔晔公子 |
首頁 上一頁 1 2 3 4 5 6 7 下一頁 末頁 (頁 |
Contact us